Mesothelioma Cancer Centers
University of Virginia Health System
Doctors Affiliated with this Treatment Facility
The University of Virginia was founded in 1819 by Thomas Jefferson and graduated its first class in medical studies in 1828. The first University Hospital, with 25 beds, was completed in 1901, and the nursing program was established that same year. A new, 682-bed hospital opened in 1960, followed by the University of Virginia Replacement Hospital in 1989.
The University of Virginia Cancer Center was established during the tenure of Robert M. Carey, M.D., who served as Dean of the School of Medicine from 1986-2002. A capital campaign resulted in the construction of a new 150,000 square-foot outpatient cancer center, which opened in 2011. The Emily Couric Clinical Cancer Center is named for former Virginia State Senator Emily Couric, sister of news anchor Katie Couric. The center aims to provide patients with state-of-the-art treatment in a setting of dignity and comfort, using ample natural light and building materials.
The Cancer Center at the University of Virginia treats mesothelioma at their lung clinic. The Lung Cancer Clinic is one of the largest and most active of its kind in the southeast, and their multidisciplinary team integrates research and clinical services to offer comprehensive care to mesothelioma patients.
Their advanced technology for detecting lung cancers include PET-CT scans and high-dose rate brachytherapy. The testing gives patients the opportunity to be diagnosed in the early stages of their cancer, allowing for a better prognosis. Their Gamma Knife radiosurgery treatment option involves radiation therapy that is targeted and strong enough to impact aggressive tumors. The center also pioneered a radiotracer localization technique, which locates and removes cancerous lung nodules. Their team typically implements multiple treatment methods alongside surgery for mesothelioma patients, including chemotherapy and radiation therapy, to give patients a comprehensive, individualized treatment plan.
Experts at the center partake in clinical cancer research, which receives more than $75 million in funding annually. They focus on basic cancer research and molecular biology, and their trials are available to patients who qualify. The center also provides palliative care services to patients who require holistic care, pain and symptom management services, in addition to hospice care and emotional support.
- Gamma Knife radiosurgery
- High-dose rate (HDR) brachytherapy
- Radiotracer localization
- Video-assisted thoracoscopic surgery (VATS)
- Ranked No. 1 hospital in Virginia by U.S. News & World Report
- National Cancer Institute (NCI) Comprehensive Cancer Center
Mesothelioma Clinical Trials at University of Virginia Health System
The following clinical trials are in progress or actively recruiting participants at University of Virginia Health System:
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Conditions: Biphasic Mesothelioma; Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v7; Stage IA Pleural Malignant Mesothelioma AJCC v7; Stage IB Pleural Malignant Mesothelioma AJCC v7; Stage II Pleural Malignant Mesothelioma AJCC v7; Stage III Pleural Malignant Mesothelioma AJCC v7 Last Updated: May 9, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette